Pharmaceuticals

At Sanofi‘s meeting on June 6th of 2019, Sanofi’s Board of Directors unanimously appointed Paul Hudson as Chief Executive Officer of the Group, to succeed Olivier Brandicourt who has decided to retire. The Board...

Novartis announced that Marie-France Tschudin, currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed President, Novartis Pharmaceuticals. She will report to Vas Narasimhan, CEO Novartis, and will join the Executive...

Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.3 billion as the Swiss drugmaker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal, announced early on...

Alcon, a division of Novartis, announced that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring...

Novartis announced an offer to acquire CellforCure from LFB. CellforCure, a French company, is one of the first and largest contract development and manufacturing organizations (CDMO) producing cell and gene therapies in Europe....

Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will report to Vas Narasimhan, CEO, Novartis, and will join the...

The European Commission has granted marketing authorization for Dengvaxia®, Sanofi‘s dengue vaccine. The marketing authorization follows the October 18, 2018, recommendation by the European Medicines Agency’s Committee for Medicinal Products for Human Use...

The inauguration and ribbon cutting ceremony of Praava Health’s model pharmacy took place at on Thursday, December 13, 2018, in Banani, Dhaka. The ceremony was led by Ms. Sylvana Q. Sinha, Founder, Managing...

Swiss group Roche Holding AG said on Wednesday its Tecentriq immunotherapy mixed with chemotherapy won priority review from the U.S. regulator for treating a type of lung cancer, a potential boost to the...

The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc’s drug to treat a form of blood cancer in newly diagnosed patients as a combination therapy. Pfizer plans to launch the drug,...